ARCHIVES

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Also Von Eschenbach’s NCI Farewell Reception, Gift Solicitation, Raises Legal And Ethical Issues.

May 5, 2006

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Varmus Pledges No Funding Gap for NCORP, Blames Snafu On “Unclear Communication”

April 11, 2014

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979